RESUMEN
BACKGROUND AND AIM: Although the esophagus is a common site of opportunistic infection in AIDS patients, little is known about the impact of HIV as well as opportunistic infection in the esophageal mucosa. Our aim is to analyze the esophageal immune profile in HIV+ patients with different immunological status with and without the opportunistic Candida infection. METHODS: Immunohistochemistry to CD4+ and CD8+ T-cells, γ-interferon, transforming growth factor-ß, interleukin (IL)-4, IL-6, IL-13, and IL-17 was performed in esophageal samples of 40 chronically HIV+ patients under highly active antiretroviral therapy (16 with Candida esophagitis, 12 virologically non-supressed with blood CD4 count < 500, and 12 virologically suppressed with blood CD4 count > 500; the latter two groups without esophageal candidiasis). The controls were 12 HIV-negative healthy individuals. RESULTS: Esophageal CD4+ T-cell expression in HIV+ patients did not differ from the control group (P = 0.50). Mucosal CD8+ T-cell expression was significantly increased in HIV+ patients (P = 0.0018). Candida esophagitis and virologically non-supressed HIV+ patients with CD4 < 500 showed an increased expression of IL-17 and IL-6 with fewer expressions of γ-interferon, more attenuated in the latter group. Transforming growth factor-ß was increased only in virologically suppressed HIV+ patients with CD4 > 500. IL-4 and IL-13 were similar to the control group. CONCLUSION: In contrast to CD8+ T-cell expression, esophageal CD4+ T-cell expression does not reflect the HIV+ patient's immunological status. T-helper 17 (Th17) response seems to play a role in the esophageal mucosa of virologically non-supressed HIV+ patients with blood CD4 < 500. Candida esophagitis showed a Th1/Th17 response but seems to be dominantly regulated by the Th17 pathway.
Asunto(s)
Candidiasis/complicaciones , Mucosa Esofágica/inmunología , Esofagitis/microbiología , Infecciones por VIH/complicaciones , Infecciones Oportunistas/complicaciones , Adulto , Linfocitos T CD4-Positivos , Linfocitos T CD8-positivos , Candidiasis/inmunología , Esofagitis/inmunología , Femenino , Infecciones por VIH/inmunología , Humanos , Interleucina-17 , Interleucina-6 , Masculino , Persona de Mediana Edad , Infecciones Oportunistas/inmunología , Factor de Crecimiento Transformador betaRESUMEN
Black esophagus is a rare but underdiagnosed disease. It occurs most frequently in severely ill patients and carries a high mortality rate. Cause of death is usually attributed to the comorbid conditions. Treatment is directed at the underlying cause, acid suppression and keeping the patient nil-per-os. Surgery is needed in complicated cases and stenosis is the most feared longterm sequel. In the present article, two cases are described and literature is reviewed.
RESUMEN
Highly active antiretroviral therapy (HAART) has dramatically decreased opportunistic infections (OIs) in human immunodeficiency virus (HIV)-infected patients. However, gastrointestinal disease continues to account for a high proportion of presenting symptoms in these patients. Gastrointestinal symptoms in treated patients who respond to therapy are more likely to the result of drug-induced complications than OI. Endoscopic evaluation of the gastrointestinal tract remains a cornerstone of diagnosis, especially in patients with advanced immunodeficiency, who are at risk for OI. The peripheral blood CD4 lymphocyte count helps to predict the risk of an OI, with the highest risk seen in HIV-infected patients with low CD4 count (< 200 cells/mm(3)). This review provides an update of the role of endoscopy in diagnosing OI in the upper gastrointestinal tract in HIV-infected patients in the era of HAART.
Asunto(s)
Enfermedades Gastrointestinales/diagnóstico , Infecciones por VIH/complicaciones , Infecciones Oportunistas/diagnóstico , Terapia Antirretroviral Altamente Activa , Biopsia , Recuento de Linfocito CD4 , Candidiasis/diagnóstico , Candidiasis/epidemiología , Infecciones por Citomegalovirus/diagnóstico , Infecciones por Citomegalovirus/epidemiología , Trastornos de Deglución/etiología , Trastornos de Deglución/microbiología , Endoscopía , Enfermedades del Esófago/diagnóstico , Enfermedades del Esófago/epidemiología , Enfermedades Gastrointestinales/inmunología , Enfermedades Gastrointestinales/microbiología , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/inmunología , Herpes Simple/diagnóstico , Herpes Simple/patología , Humanos , Infecciones Oportunistas/prevención & control , Prevalencia , Gastropatías/diagnóstico , Gastropatías/microbiologíaRESUMEN
BACKGROUND AND AIM: Dyspeptic symptoms are frequently reported by human immunodefficiency virus (HIV)-infected patients under highly active antiretroviral therapy. Whether opportunistic infections are a cause of dyspepsia is still unknown. In this study we prospectively compare the prevalence of gastrointestinal opportunistic infections in dyspeptic versus non-dyspeptic HIV-infected patients with advanced immunodeficiency. PATIENTS AND METHODS: Six hundred and ninety HIV-infected patients under highly active antiretroviral therapy underwent esophagogastroduodenoscopy with mucosal biopsies from the stomach and duodenum. Group 1: 500 patients (161 women, 339 men; mean age 38.8 years; mean CD4 count 154.3 cells/mm(3) with dyspeptic symptoms such as epigastric pain, nausea, vomiting and fullness. Group 2: 190 patients (169 men, 21 women; mean age 40.7 years; mean CD4 count 171.6 cell/mm(3)) with no dyspeptic symptoms. RESULTS: Group 1: Gastrointestinal opportunistic infections were observed in eight (1.6%), and non-opportunistic parasites in two (0.4%), patients. They were: Cytomegalovirus (four patients), Cryptosporidium sp. (two patients), Schistosoma mansoni sp. (one patient), Strongyloides stercoralis (one patient) and Giardia sp. (two patients). In five patients esophagogastroduodenoscopy showed no mucosal lesions. Group 2: Giardia sp. was detected in two patients (1.1%: P = 0.07947). CONCLUSION: Gastrointestinal opportunistic infections were shown in a small number of HIV-infected patients under highly active antiretroviral therapy with advanced immunodeficiency. Although gastrointestinal opportunistic infections were detected exclusively in the dyspeptic patient group, they could not be related to these symptoms, since the number of infected patients was not statistically significant. To correctly diagnose opportunistic infections, multiple biopsy specimens may be necessary even from normal-appearing mucosa.
Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/epidemiología , Dispepsia/epidemiología , Mucosa Gástrica/patología , Enfermedades Gastrointestinales/epidemiología , Infecciones por VIH/tratamiento farmacológico , Mucosa Intestinal/patología , Infecciones Oportunistas Relacionadas con el SIDA/patología , Adulto , Terapia Antirretroviral Altamente Activa , Biopsia , Brasil/epidemiología , Estudios de Casos y Controles , Dispepsia/patología , Endoscopía del Sistema Digestivo , Femenino , Enfermedades Gastrointestinales/patología , Infecciones por VIH/epidemiología , Infecciones por VIH/virología , Humanos , Masculino , Prevalencia , Estudios Prospectivos , Resultado del TratamientoRESUMEN
BACKGROUND AND AIM: Upper gastrointestinal symptoms, mainly dyspepsia, are common adverse effects in patients under highly active antiretroviral therapy (HAART). Whether it is worthwhile to perform endoscopy early in their treatment is a matter of debate. We have done a prospective study of the prevalence and the etiology of endoscopic lesions in a large cohort of dyspeptic adult HIV-infected patients under HAART, according to their immunological status. METHODS: 528 (334 men and 194 women, mean age 38) HIV-infected patients under HAART with epigastric pain and/or nausea and vomiting underwent upper endoscopy. Patients were classified in two groups, according to CD4 cells counting (>200 cells/mm(3) or < or =200 cells/mm(3)). Gastric and duodenal biopsies were taken from normal mucosa and any lesion found. RESULTS: Gastric mucosa alterations were seen in 61.74% of patients (40.71% erythema, 18.38% erosion and 2.65% ulcer). Duodenum mucosa alterations were seen in 25.37% of patients, mainly erosions (19.50%) and ulcer (3.59%). There was no difference in endoscopic findings according to CD4 cell count groups. Chronic active gastritis was shown in 459 patients (86.93%). H. pylori infection was seen in 32.38%, and it was more prevalent in the group with CD4 > 200 (p < 0.01). Opportunistic infections and malignancies were seen exclusively in patients with CD4 < or = 200. CONCLUSIONS: Most of the endoscopic lesions in dyspeptic HIV-infected patients under HAART were not related to AIDS. Upper endoscopy was more helpful in dictating clinical treatment in patients with low CD4 counts (< or =200) and should be done earlier in this group.
Asunto(s)
Fármacos Anti-VIH/efectos adversos , Duodenoscopía , Duodeno/efectos de los fármacos , Dispepsia/inducido químicamente , Gastroscopía , Infecciones por VIH/tratamiento farmacológico , Estómago/efectos de los fármacos , Dolor Abdominal/inducido químicamente , Dolor Abdominal/patología , Adulto , Terapia Antirretroviral Altamente Activa , Recuento de Linfocito CD4 , Duodeno/microbiología , Duodeno/patología , Dispepsia/epidemiología , Dispepsia/microbiología , Dispepsia/patología , Femenino , Gastritis/microbiología , Gastritis/patología , Infecciones por VIH/epidemiología , Infecciones por VIH/inmunología , Infecciones por VIH/microbiología , Infecciones por VIH/patología , Infecciones por Helicobacter/microbiología , Infecciones por Helicobacter/patología , Helicobacter pylori , Humanos , Masculino , Náusea/inducido químicamente , Náusea/patología , Prevalencia , Estudios Prospectivos , Factores de Riesgo , Estómago/microbiología , Estómago/patología , Factores de Tiempo , Resultado del Tratamiento , Vómitos/inducido químicamente , Vómitos/patologíaRESUMEN
Strongyloidiasis is an endemic tropical parasitosis caused by Strongyloides stercoralis that also affects immigrants in nontropical countries. The nematode colonizes the duodenum and upper jejunum, inducing mucosal alterations. Because integrity is essential for a functional barrier, we aimed to study apoptosis and proliferation in the small bowel epithelium infected with S. stercoralis. We evaluated 23 patients and 17 controls. Apoptotic cells were detected by TUNEL and M30 immunolabelling, whereas proliferation was scored by Ki67 immunostaining and mitotic counting. Infection increased apoptotic indices in duodenum and jejunum (P < 0.001). Conversely, it decreased cell proliferation in both segments (P < 0.001). Our results showed that intestinal strongyloidiasis promotes an imbalance between cell death and proliferation. This is the first evidence of disruption of the epithelial kinetics with S. stercoralis infection, though the mechanisms remain unclear. Furthermore, our results support the idea that strongyloidiasis disturbs the mucosal integrity and can compromise the intestinal barrier.
Asunto(s)
Duodeno/parasitología , Yeyuno/parasitología , Estrongiloidiasis/patología , Adulto , Animales , Apoptosis , Estudios de Casos y Controles , Proliferación Celular , Duodeno/citología , Epitelio/parasitología , Epitelio/patología , Femenino , Humanos , Inmunohistoquímica , Etiquetado Corte-Fin in Situ , Yeyuno/citología , Masculino , Persona de Mediana Edad , Strongyloides stercoralisRESUMEN
Os autores revisam os fatores envolvidos na formaçäo dos calculos de colesterol da vesicula biliar: supersaturacao biliar de colesterol, nucleaçäo e formaçäo dos cristais de colesterol e hipomotilidade vesicular